Postsynaptic density protein 95–NMDA receptor subunit 2B–neuronal nitric oxide synthase complex (PSD-95/NR2B/nNOS complex)

The Postsynaptic density protein 95–NMDA receptor subunit 2B–neuronal nitric oxide synthase complex is a postsynaptic multiprotein signaling assembly in neurons, centered around the scaffolding protein PSD-95. PSD-95 organizes the complex by binding NR2B (GluN2B), a subunit of the NMDA-type glutamate receptor, via its PDZ domains, and simultaneously binds nNOS (neuronal nitric oxide synthase) via a noncanonical PDZ-mediated interaction[1][2][4][5]. This proximity is critical for efficiently coupling NMDA receptor-mediated calcium influx to NO production by nNOS. While essential for normal synaptic plasticity, memory, and neuronal communication, this complex becomes pathogenic under excitotoxic conditions such as stroke or neurodegeneration, where it mediates neuronal injury through excessive NO and oxidant production[1][2][4][5]. Targeting this complex with small molecules or peptides that disrupt its assembly is a promising neuroprotective strategy, as it can prevent pathological signaling without blocking physiological NMDA receptor or nNOS activity[5]. The complex is also implicated in pain, psychiatric disorders, and repair after brain injury[3][5]. For drug development, the key innovation is selectively uncoupling pathologic protein–protein interactions (e.g., with Tat-NR2B9c, ZL006, or IC87201) to achieve functional selectivity and reduced adverse effects compared to direct receptor or enzyme inhibition[2][5].

Other names

PSD-95/NR2B/nNOS ternary complexPostsynaptic density protein 95–NR2B–nNOS complexNMDAR–PSD-95–nNOS complex

Disruption of protein-protein interactions to block pathologic NO signaling without global NMDA receptor inhibition; Allosteric modulation of NR2B to reduce excitotoxicity; Interference in scaffold assembly to uncouple excessive calcium influx from downstream neurotoxic cascades